Nordic Naturals Ultimate Omega

Provides 1280mg omega-3s (650mg EPA, 450mg DHA) per 2-softgel serving in absorbable triglyceride form. Evidence for cardiovascular benefit is mixed: primary-prevention trials (VITAL) showed no major-event reduction, while high-dose EPA (REDUCE-IT) and meta-analyses suggest dose-dependent benefit. Not medical advice.

Check price on Amazon Live price & reviews on Amazon
Heart & Brain — illustrative scene
If you skip fish
650 mg EPA + 450 mg DHA (1280 mg total) EPA + DHA per serving Nordic Naturals ↗
Increasing EPA/DHA has little or no effect on deaths and cardiovascular events (high-certainty evidence) General-population evidence Cochrane Review (Abdelhamid et al.) ↗
Risk reductions appeared linearly related to marine omega-3 dose (dose-dependent) Dose matters Hu/Manson meta-analysis (J Am Heart Assoc) ↗
Amazonia reader ratings

Rate this pick

Our own community ratings — from confirmed Amazonia readers, never Amazon. Yours helps the next person decide, and steers what we feature next.

Ratings loading…

What the research says

  • “Supplementation with n-3 fatty acids did not result in a lower incidence of major cardiovascular events or cancer than placebo.”

    In VITAL (25,871 adults), 1 g/day marine omega-3 did NOT reduce major cardiovascular events vs placebo, though secondary analyses suggested fewer heart attacks, especially in low-fish-eaters.

    Manson JE et al., New England Journal of Medicine (VITAL) · 2019 ↗
  • “icosapent ethyl reduced total primary endpoint events (61 vs. 89 per 1,000 patient-years for icosapent ethyl versus placebo, respectively; rate ratio: 0.70; 95% confidence interval: 0.62 to 0.78; p < 0.0001)”

    In REDUCE-IT, high-dose prescription EPA (4 g/day) reduced ischemic events in statin-treated patients with high triglycerides, but raised atrial-fibrillation and bleeding risk — a far higher, purified dose than any OTC fish oil.

    REDUCE-IT total-events analysis, JACC · 2019 ↗
  • “Risk reductions appeared to be linearly related to marine omega‐3 dose.”

    Meta-analysis of 13 RCTs (127,477 participants) found marine omega-3 associated with modestly lower risk of myocardial infarction and CHD death (not stroke), with benefit appearing dose-dependent.

    Hu Y, Manson JE et al., J. Am. Heart Assoc. · 2019 ↗

Educational summary of the research — not medical or veterinary advice. Evidence strength varies and individual results differ; talk to a qualified professional before changing your (or your pet's) health routine.

How it compares

Fish oil (EPA/DHA)Algae omega-3Krill oil
Source Wild-caught fishCultivated algae (vegan)Antarctic krill
Provides EPA + DHA Yes, both, high doseYes (often DHA-dominant)Yes, lower per capsule
Dose to hit ~1000mg+ EPA+DHA 1-2 softgels1-2 softgelsSeveral capsules
Notes rTG aids absorptionBest vegan option, pricierPhospholipid form, lower potency

Buy it if

  • People who eat little fatty fish and want to raise EPA/DHA intake
  • Buyers who prioritize absorbable triglyceride form and traceable sourcing
  • Those wanting a high dose per serving without taking many capsules
  • Higher-risk individuals advised by a clinician to supplement

Skip it if

  • People who already eat 2+ servings of fatty fish weekly
  • Anyone expecting it to prevent or treat heart disease
  • Vegans/vegetarians (choose an algae-based omega-3)

The verdict

A well-formulated, transparently sourced, high-potency triglyceride-form fish oil — among the better OTC options. But buy it for honest reasons: omega-3 cardiovascular evidence is mixed, with no proven major-event reduction in general-population supplementation. Dietary support, not disease prevention. Not medical advice.

Check price on Amazon Live price & reviews on Amazon

Questions, answered

Is the triglyceride form actually better?
Studies suggest triglyceride/rTG omega-3s absorb somewhat better than the ethyl-ester form in many low-cost supplements. It's a real formulation advantage, though it matters more for absorption efficiency than any specific outcome. Source Dyerberg et al. 2010, bioavailability (PLEFA) ↗
Will this prevent heart disease?
No supplement should be sold on that promise. Evidence is genuinely mixed: general-population trials (VITAL) found no reduction in major events, while high-dose prescription EPA (REDUCE-IT) helped specific higher-risk groups. Treat it as dietary support. Talk to your doctor. Source Manson et al., NEJM (VITAL) ↗REDUCE-IT total-events analysis, JACC ↗
How does the dose compare to research?
At 1280mg total omega-3 per serving it exceeds the ~840mg-1g/day used in VITAL, but is far below the 4g/day purified EPA in REDUCE-IT. Meta-analysis data suggest benefit may be dose-dependent above ~840mg/day. Source Manson et al., NEJM (VITAL) ↗Hu/Manson et al., J. Am. Heart Assoc. ↗